Evidence map›Paper›PMID 41566083›Full record

ArticleVirchows Archiv : an international journal of pathology2026

Primary cutaneous non neuroendocrine small cell carcinoma POU2F3 subtype: morphologic, immunohistochemical, transcriptomic and methylation analysis of two cases.

Kerman Zyani, Daniel Pissaloux, Charly Liddell, Mahtab Samimi, Franck Tirode, Andreas von Deimling, Serge Guyétant, Sylvie Lantuejoul, Thibault Kervarrec

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kerman ZyaniDepartment of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
Daniel PissalouxDepartment of Biopathology, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, INSERM U1052 - CNRS UMR5286, Université Claude Bernard Lyon 1, Lyon, France.
Charly LiddellDepartment of Pathology, Hospital of La Roche Sur Yon, La Roche-sur-Yon, France.
Mahtab SamimiDepartment of Dermatology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
Franck TirodeDepartment of Biopathology, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, INSERM U1052 - CNRS UMR5286, Université Claude Bernard Lyon 1, Lyon, France.
Andreas von DeimlingDepartment of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany.
Serge GuyétantDepartment of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France.
Sylvie LantuejoulDepartment of Biopathology, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, INSERM U1052 - CNRS UMR5286, Université Claude Bernard Lyon 1, Lyon, France.
Thibault KervarrecDepartment of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France. thibaultkervarrec@yahoo.fr.ORCID http://orcid.org/0000-0002-2201-6914

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Up to 10% of small cell lung carcinomas do not express any neuroendocrine markers and are characterized by an expression of the transcription factor POU2F3. Recently, few cases of poorly differentiated carcinomas harboring POU2F3 expression have been described in the breast, cervix, and bladder. Herein, we report the morphological, immunohistochemical, and molecular characterization of two primary cutaneous POU2F3-expressing small cell carcinomas. The cases arose in the temple and on the occipital region in a 92-year-old woman and a 78-year-old man respectively. Microscopic examination revealed in both cases a large and ulcerated poorly differentiated neoplasm infiltrating the full thickness of the dermis with extension into the subcutaneous tissues in case #1. The tumors harbored solid and trabecular growth patterns and were composed of poorly differentiated highly mitotic cells. Immunohistochemical investigation revealed diffuse pancytokeratin positivity while no expression of cytokeratin 20, chromogranin A, synaptophysin, CD56, or INSM1 was detected. Diffuse nuclear expression of POU2F3 was observed. Transcriptomic analysis revealed a SBS7 mutation signature related to UV-induced DNA damages in one case and evidenced an expression profile similar to the one observed in POU2F3-expressing small cell lung cancers in both. Methylation analysis confirmed the proximity of the two cases with other skin cancers. To conclude, we report herein the first description of primary cutaneous small cell carcinoma POU2F3 subtype.

Indexed as

CarcinomaNeuroendocrine differentiationPOU2F3 subtype

Identifiers

PMID41566083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.